Premium
An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia ( THETIS ): 5‐year results
Author(s) -
Lai YongRong,
Cappellini Maria Domenica,
Aydinok Yesim,
Porter John,
Karakas Zeynep,
Viprakasit Vip,
Siritanaratkul Noppadol,
Kattamis Antonis,
Liu Rongrong,
Izquierdo Miguel,
Lasher Janet,
Govindaraju Sameera,
Taher Ali
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26592
Subject(s) - deferasirox , thalassemia , medicine , multicenter study , blood transfusion , open label , gastroenterology , adverse effect , randomized controlled trial
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom